Molecular Epidemiology of a Citywide Outbreak of Extended‐Spectrum β‐Lactamase–ProducingKlebsiella pneumoniaeInfection
Author(s) -
John Quale,
David Landman,
Patricia A. Bradford,
M Visalli,
Jayshree Ravishankar,
Carlos Flores,
David Mayorga,
Kalyani Vangala,
Adedeyo Adedeji
Publication year - 2002
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/342577
Subject(s) - klebsiella pneumoniae , cefepime , cefoxitin , medicine , amikacin , microbiology and biotechnology , outbreak , ciprofloxacin , molecular epidemiology , piperacillin , ceftazidime , epidemiology , pneumonia , ceftriaxone , cephalosporin , antibiotics , multiple drug resistance , imipenem , virology , biology , antibiotic resistance , genotype , pseudomonas aeruginosa , bacteria , staphylococcus aureus , escherichia coli , biochemistry , genetics , gene
Multidrug-resistant strains of Klebsiella pneumoniae are a problem in many hospitals. In 1999, the molecular epidemiology of K. pneumoniae with extended-spectrum beta-lactamases (ESBLs) was studied at 15 hospitals in Brooklyn. Of 824 unique patient isolates, 34% were presumptive ESBL producers. Of this subset, 34% were susceptible to cefoxitin, 42% to ciprofloxacin, 48% to ceftriaxone, 55% to piperacillin-tazobactam, 57% to amikacin, and 86% to cefepime. Ribotype analysis revealed 87 unique types. However, 2 clusters accounted for 35% of isolates and were present in most of the hospitals. One cluster was significantly more resistant to most antibiotics. Although there was a predominance of SHV-5, considerable heterogeneity of beta-lactamases was evident, even among isolates of the same cluster. A correlation was found between the use of cephalosporins and the prevalence of ESBL-producing strains of K. pneumoniae at each hospital. Our data suggest that there is an advanced outbreak of multidrug-resistant K. pneumonia infection that is affecting all Brooklyn hospitals.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom